New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
12:31 EDTS, HUM, AEGR, SFTBF, AMED, YONG, CLWR, DCTH, COn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday following a report that showed surprisingly strong retail sales in September. The averages started out slightly higher and seemed to have trouble gaining any upside momentum in the early hours of trading. The reaction to the better than expected retails sales figures seemed to be muted by the disappointing Empire manufacturing data. Following the report on August business inventories the averages actually crossed into negative territory, before reversing and drifting higher. The averages stood near session highs around noon as this week begins more positively for the markets than last week... ECONOMIC EVENTS: In the U.S., retail sales rose 1.1% in September, versus expectations for an increase of 0.8%. The core reading, minus auto and gas components, increased 0.9%, versus expectations for a 0.4% gain. The Empire Manufacturing Index had a reading of -6.16, versus expectations for a reading of -4.0. Business inventories reportedly increased 0.6% in August, versus expectations for an increase of 0.5%. In China, a raft of data was reported over the weekend, including better than expected export numbers. Chinese export growth accelerated to 9.9% and import growth accelerated to 2.4%, but some irregularities kept investors and analysts cautious about the results. Also, China's consumer-price index eased in line with expectations and a gauge of producer prices showed a steepening drop, fueling speculation that the government may take further monetary stimulus action... COMPANY NEWS: Japan's SoftBank (SFTBF) confirmed a deal to purchase a 70% stake in Sprint (S) for about $20B. Shares of Sprint were down fractionally after the details of the previously speculated arrangement were publicized. However, moving up again were shares of Sprint partner Clearwire (CLWR), which rose 11% though Sprint CEO Dan Hesse said he would not speculate on what Sprint will do with its new-found financial flexibility... Shares of Citigroup (C) jumped nearly 5% as its third quarter earnings beat expectations after its write down of the value of its remaining stake in Smith Barney and some other adjustments were excluded... MAJOR MOVERS: Among the notable gainers were Yongye International (YONG), up 17% following its receipt of "going private" proposal at $6.60 per share, and Aegerion Pharmaceuticals (AEGR), up 9% after the FDA posted briefing documents for a panel's upcoming review of one of the company's drugs. Among the noteworthy losers was Delcath Systems (DCTH), down over 18% after the FDA accepted the company's New Drug Application for its chemosaturation system and designated the NDA for standard review. Also lower were shares of Amedisys (AMED), down 9% after the company signed a new agreement with Humana (HUM) to provide home health services but under a revised reimbursement scheme from their prior arrangement... INDICES: Near noon, the Dow was up 67.40, or 0.51%, to 13,396.25; the Nasdaq was up 9.07, or 0.30%, to 3,053.18; and the S&P 500 was up 6.88, or 0.48%, to 1,435.47.
News For S;CLWR;SFTBF;C;YONG;AEGR;DCTH;AMED;HUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 28, 2015
10:00 EDTAEGROn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aegerion (AEGR) upgraded to Buy from Hold at Jefferies... Ameren (AEE) upgraded to Neutral from Sell at Goldman... AutoNation (AN) upgraded to Buy from Neutral at Sterne Agee CRT... Beacon Roofing (BECN) upgraded to Outperform at Baird... BlackBerry (BBRY) upgraded to Equal Weight from Underweight at Morgan Stanley... Bojangles (BOJA) upgraded to Buy from Neutral at SunTrust... Boyd Gaming (BYD) upgraded to Neutral from Underperform at BofA/Merrill... Columbus McKinnon (CMCO) upgraded to Buy from Neutral at Sidoti... Danaher (DHR) upgraded to Overweight from Equal Weight at Morgan Stanley... Emerald Oil (EOX) upgraded to Hold from Sell at Wunderlich... Haemonetics (HAE) upgraded Outperform from Market Perform at Barrington... Jefferies sees entry point for Aegerion (AEGR), upgrades to Buy... Philips (PHG) upgraded to Buy from Hold at Societe Generale... Plum Creek Timber (PCL) upgraded to Buy from Neutral at DA Davidson... Raytheon (RTN) upgraded to Buy from Neutral at BofA/Merrill... SandRidge Energy (SD) upgraded to Hold from Sell at Wunderlich... Telecom Argentina (TEO) upgraded to Outperform from Market Perform at Raymond James... Teva (TEVA) upgraded to Outperform from Market Perform at BMO Capital... Triumph Bancorp (TBK) upgraded to Buy from Hold at Evercore ISI... Waste Management (WM) upgraded on valuation, rebounding businesses at Argus... Wisconsin Energy (WEC) upgraded to Buy from Neutral at Goldman.
09:32 EDTCCaterpillar announces $1.5B accelerated stock repurchase
Subscribe for More Information
07:34 EDTAEGRJefferies sees entry point for Aegerion, upgrades to Buy
Subscribe for More Information
06:10 EDTAEGRAegerion upgraded to Buy from Hold at Jefferies
Subscribe for More Information
July 27, 2015
17:03 EDTDCTHMitchell Kopin reports 6.7% passive stake in Delcath Systems
13:24 EDTHUMRegulators to consider 'too big to fail' in health insurance reviews, CTFN says
Subscribe for More Information
08:19 EDTAEGRAegerion sees Q2 net product sales $63M-$64M, consensus $56.94M
Subscribe for More Information
08:17 EDTAEGRAegerion appoints Smith as interim CEO
Subscribe for More Information
08:10 EDTHUMLeerink sees at least 60% chance of Anthem, Cigna deal being approved
Subscribe for More Information
July 26, 2015
18:22 EDTHUMMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
July 24, 2015
10:46 EDTCCiti's Mexico unit facing expanding money laundering probe, Bloomberg says
Subscribe for More Information
July 23, 2015
07:22 EDTSSprint price target lowered to $3 from $4 at Jefferies
Subscribe for More Information
July 22, 2015
16:26 EDTCCiti releases results of 2015 Dodd-Frank Stress Test
Subscribe for More Information
12:58 EDTCCiti says to wind down banking operations at Banamex USA
Subscribe for More Information
12:53 EDTCFDIC announces $140M civil penalty against Citi's Banamex USA unit
The FDIC announced the assessment of a civil money penalty of $140M against Banamex USA, Century City, California, for violations of the Bank Secrecy Act and anti-money laundering laws and regulations. In a concurrent action, the California Department of Business Oversight assessed a civil money penalty of $40M. The FDIC's penalty of $140M will be satisfied in part by the CDBO's penalty. The FDIC's penalty will be paid to the United States Department of the Treasury. In taking this action, the FDIC determined that the bank failed to implement an effective BSA/AML Compliance Program over an extended period of time. The institution failed to retain a qualified and knowledgeable BSA officer and sufficient staff, maintain adequate internal controls reasonably designed to detect and report illicit financial transactions and other suspicious activities, provide sufficient BSA training, and conduct effective independent testing.
July 21, 2015
10:58 EDTCCiti fined $70M, ordered by CFPB to provide $700M in relief
Subscribe for More Information
July 20, 2015
16:01 EDTCOptions Update; July 20, 2015
Subscribe for More Information
13:03 EDTCFed proposes final rule on capital surcharges for largest U.S. banks
Subscribe for More Information
10:05 EDTHUMHumana renews, lengthens SilverSneakers pact with Healthways
Subscribe for More Information
08:07 EDTDCTHDelcath Systems's melphalan granted Orphan Drug Designation by FDA
Delcath Systems announced that the FDA Office of Orphan Products Development, or OOPD, has granted Orphan Drug Designation for melphalan for the treatment of cholangiocarcinoma. The OOPD is tasked with evaluating the scientific and clinical data submissions from sponsors to identify and designate products as promising for rare diseases and to further advance scientific development of such promising medical products.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use